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Abstract
Background: Platelet-activating factor and nitric oxide may be involved in the initiation of human
labour as inflammatory mediators. The aim of this study was to test whether platelet-activating
factor and lipopolysaccharide were able to induce nitric oxide synthase expression and stimulate
the production of nitric oxide in human fetal membrane explants in culture.
Methods: Fetal membranes were collected from Caesarean sections at term. RNA was extracted
from membranes and subjected to a qualitative RT-PCR to assess the baseline expression of iNOS.
Discs of fetal membranes were cultured for 24 hours in the presence of platelet-activating factor
at a dose range of 0.1 nanomolar – 1 micomolar or 1 microgram/ml lipopolysaccharide. Nitric oxide
production was measured via nitrite ions in the culture medium and mRNA for iNOS was detected
by RT-PCR.
Results: Culturing the membrane discs in medium containing serum induced nitric oxide synthase
expression and platelet-activating factor significantly stimulated the production of nitric oxide
under these conditions. When cultured without serum inducible nitric oxide synthase expression
was induced by lipopolysaccharide, but not by platelet-activating factor.
Conclusion: Platelet-activating factor may have a role in the initiation of labour, at term or
preterm, via the increased local production of nitric oxide as an inflammatory mediator. In this
model of intrauterine infection, lipopolysaccharide was found to induce iNOS expression by fetal
membranes, and this mechanism could be involved in preterm labour.
Background
Preterm birth is a major obstetric problem, affecting up to
10% of births in the UK and USA [1]. Intrauterine infec-
tion is a known risk factor for preterm labour and is asso-
ciated with the pathology of the condition [2-4]. Bacteria
and bacterial products, such as lipopolysaccharide (LPS)
induce the production of inflammatory mediators, such
as prostaglandin E2 and F2α [5] and IL-6 and IL-8 [6], by
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intact fetal membranes in culture. Platelet-activating fac-
tor (PAF) may also have a role in preterm labour and
increased levels of PAF in amniotic fluid (up to 44.1 ng/
ml, 79.9 nM) before 37 weeks of gestation have been asso-
ciated with premature labour [7]. The exact mechanisms
involved in the initiation of human parturition have yet to
be fully elucidated. There is growing evidence for an
inflammatory mechanism in the onset of labour at term
[8] and preterm [9,10], where inflammatory mediators
such as PAF and nitric oxide (NO) may be involved. It has
been thought for some time that PAF could be involved
with the onset of parturition [11,12], as PAF is associated
with fetal lung maturation and is produced by type II
pneumocytes, along with surfactant [12,13]. It is trans-
ferred from the fluid in the lungs into the amniotic fluid
in late gestation, by diffusion or fetal breathing move-
ments [11,12]. Levels of PAF are thought to increase in the
amniotic fluid towards term [14-16]. The mean concen-
tration of PAF in samples of amniotic fluid obtained after
spontaneous labour and vaginal delivery at term has been
determined as 0.1 nM [17], with a form identified with an
octadecyl side chain [15]. PAF is a highly potent inflam-
matory mediator [18] and has been shown to stimulate
the production of prostaglandins from fetal membranes
[19]. A link between PAF and iNOS in other tissues has
been suggested by Qu et al. [20] and PAF has been found
to evoke release of NO from human endometrium
[21,22]. The local application of PAF was found to induce
cervical ripening in rats, via infiltration of polymorphonu-
clear leukocytes [23]. Nitric oxide has also been found to
be a mediator of cervical ripening, via an inflammatory
mechanism [24], suggesting a role in promoting
parturition.
It is well established that inducible nitric oxide synthase
(iNOS) can liberate high concentrations of NO locally
[25]. This enzyme is not expressed constitutively and is
normally absent from cells until they are stimulated by
cytokines or growth factors [26,27]. Butyrate, a metabolite
produced by some anaerobic bacteria, has been shown to
promote the expression of iNOS in a cell line in culture
[28]. Expression of iNOS mRNA has been previously iden-
tified in human fetal membranes at term, specifically in
the amnion, chorio-decidua and placenta [29]. Immunos-
taining has shown the presence of iNOS in fibroblasts of
the mesenchyme of amnion and chorion and in decidual
macrophages [30]. NO metabolite concentrations were
found to be higher in amniotic fluid collected from
labouring compared to non-labouring women, both at
term and preterm [31]. Increased staining for iNOS was
detected in trophoblast cells from women in labour com-
pared to non-labouring [31], however Kakui et al. [32]
reported no difference in iNOS expression in placental tis-
sues for women in labour compared to those not in
labour. Upregulated expression of iNOS was reported in
human cervical biopsies obtained during the third trimes-
ter compared to the first trimester [33].
A robust model for maintaining human fetal membrane
explant discs (comprising amnion, chorion and decidua)
in culture has been established and validated by Sullivan
[19]. It is common practice in tissue culture to include
serum in the culture medium, however it has been found
that exposure to serum can induce the expression of some
enzymes, such as COX-2 [34]. For this reason, intact fetal
membrane explants were used in this study with and with-
out serum in the culture medium.
The aim of this study was to investigate whether PAF and
LPS were able to induce iNOS mRNA expression and to
stimulate the production of nitric oxide in intact human
fetal membrane explants in culture.
Methods
Tissue collection
Human fetal membranes were obtained from elective
Caesarian sections at term (n = 22; pre-labour), with
informed consent and the ethical approval of the Wolver-
hampton District Local Research Ethics Committee, in
compliance with the Helsinki Declaration. Four samples
of fetal membranes were collected after normal vaginal
delivery, to provide a post-labour comparison. The preg-
nancies and deliveries were free of any complications and
were singletons. It was not known whether antibiotics
were administered to the women before delivery.
Tissue culture
Following collection, the pre-labour membranes were
washed with sterile phosphate buffered saline (PBS, pH
7.4) and discs 2.5 cm in diameter were punched out.
Some sample discs of the fresh membranes were immedi-
ately homogenised and the RNA extracted by the guanid-
ium thiocyanate-phenol method (TRI Reagent®) for
subsequent analysis. 12 disks were washed twice with ster-
ile PBS and transferred to two 6 well plates containing 2
ml HAM'S F-12 medium, with 50 units of penicillin and
50 µg streptomycin per ml. Six sets of the membrane sam-
ples were cultured with 10% fetal calf serum and nine sets
were cultured without serum in the culture medium (Fig-
ure 1). The discs were cultured for 24 hours at 37°C in 5%
CO2 in humid air, to allow for recovery. Following this,
the medium was removed and replaced with either fresh
medium (control, n = 4) or medium containing 1 µg/ml
LPS (n = 4) or medium containing 1 µg/ml LPS + 2 mM
sodium butyrate (n = 4) (Figure 1). For a further 5 samples
of membranes, the medium was removed and replaced
with either fresh medium (control, n = 5) or medium con-
taining PAF at 0.1 nM, 1.0 nM, 10 nM, 100 nM or 1.0 µM
(n = 5) (Figure 1). All concentrations were chosen to be
consistent with other published studies and to cover theReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/29
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physiological range. For the membrane discs cultured
with serum, control (n = 3) and PAF at 1.0 µM (n = 3) only
were used (Figure 1). As PAF is extremely lipid soluble,
solutions were made up using culture medium, which
contained sufficient surfactants to act as carriers for PAF.
After 24 hours in culture the membrane discs and super-
natants were removed from each well. The time period for
culture was selected following a time profile study. The
discs were immediately homogenised and the RNA
extracted using TRI Reagent® for subsequent analysis. The
concentration of nitrite ions (NO2
-), an oxidised product
of NO, was measured immediately in the supernatants by
a standard Griess reagent assay [35]. Culture medium was
used as a blank in the assay to allow for the content of
NO2
-. The viability of the cells comprising the membrane
discs in culture was assessed by a standard diaphorase
staining technique [5,19].
RT-PCR for iNOS
The presence of specific mRNA for iNOS in the membrane
discs was detected by a qualitative reverse transcription-
polymerase chain reaction (RT-PCR) method. For the
reverse transcription 2 µl of total fetal membrane RNA
(approx. 400 µg/ml) was reverse-transcribed to cDNA
using an AMV-Reverse Transcription System (Promega,
Southampton, UK). The reverse transcription was per-
formed according to the manufacturer's protocol using
random hexamer primers. The PCR primers used were: 5'-
GAGCTTCTACCTCAAGCTATC-3' (iNOS sense, bases
517–537) and 5'-TGATGTTGCCATTGTTGGTGG-3'
(iNOS antisense, bases 806–826 of the human iNOS
cDNA). The PCR conditions were: 2 m 30 s at 94°C, 45 s
at 60°C, 5 m 30 s at 72°C (45 cycles). The reaction mix
was: 10x PCR buffer (Stratagene, Cambridge, UK) 2.00 µl,
dNTP Mix (Promega, Southampton, UK) 10 mM 0.50 µl,
Sense primer (Oswel, Southampton, UK) 10 µM 0.40 µl,
Antisense primer (Oswel, Southampton, UK), 10 µM 0.40
µl, Taq 2000™ polymerase (Stratagene, Cambridge, UK) 5
units/µl 0.04 µl, Nuclease-free water (Promega, South-
ampton, UK) 16.50 µl, cDNA template 2.00 µl. Total vol-
ume 21.84 µl.
Nested RT-PCR for iNOS
The amplified product was confirmed as human iNOS
DNA by specific nested RT-PCR and DNA sequencing.
Nested RT-PCR was used to detect low-level expression of
Summary of the fetal membrane samples and protocols used Figure 1
Summary of the fetal membrane samples and protocols used.
 
Pre-labour  (n  =  22)        Post-labour  (n  =  4) 
 
Inactive – not expressing iNOS  Active - expressing iNOS 
(n = 19)        (n = 3) 
           
                    Immunocytochemistry   
        ( n   =   4 )  
 
Cultured with serum    Cultured without serum    Immunocytochemistry  
(n  =  6)     (n  =  9)     (n  =  4) 
 
 
PAF treated  Serum only  PAF treated  LPS treated 
(n = 3)   (n = 3)   (n = 5)   (n = 4) 
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iNOS mRNA. The designed nested primers used were:
sense primer (5'-GTCAACCAATATTACGGCTC-3'), posi-
tioned between bases 544–563; antisense primer (5'-
AGTAACGCACGTGTCTGCAG-3'), located between bases
786–805 of the human iNOS cDNA. The PCR conditions
were the same as for the standard RT-PCR method. PCR
products were fractionated by gel electrophoresis using a
2% agarose gel stained with ethidium bromide. Molecular
weight markers for DNA, ΦX174 DNA/Hae III Marker
(Promega, Southampton, UK), were run on the gels for
reference. A cell line of Chinese hamster ovary cells trans-
fected with the gene for human iNOS, so that they consti-
tutively expressed iNOS (CHOiNOS), were used as a
positive control for the RT-PCR method [28].
Immunohistochemistry
Human fetal membranes were collected after normal vag-
inal delivery (post-labour, n = 4) or at Caesarean section
at term (pre-labour, n = 4) (Figure 1). Squares of 1 cm2
were cut from human fetal membranes, at sites close to
the placenta. The sample sections were snap-frozen imme-
diately in a slush of dry ice in isopentane. Microsections
of 6 µm thickness were cut at -20°C using a cryostat
microtome. The sections were mounted on Vectabond-
coated slides and immediately fixed in acetone. For
immunohistochemical staining, the primary antibody
was a monoclonal anti-human iNOS antibody, clone
2A1-F8 (R&D Systems, Oxford, UK). Several antibodies to
human iNOS were trialled and the antibody used was
found to be the best available at the time and was fully
validated. The antibody was used at 10 µg/ml in Western
blotting buffer (25 mM Tris, 0.5 M NaCl, 0.05% Tween
20) at pH 7.5, containing 2% nonfat dry milk. After add-
Table 1: Summary of results for iNOS expression and NO production for fetal membrane disks cultured in the absence or presence of 
serum
Serum Free With Serum
LPS PAF LPS PAF
iNOS expression Induction (n = 4) No induction (n = 5) N/A* N/A*
NO production No increase (n = 4) No increase (n = 5) N/A* Increase (n = 3)
* These experiments were not performed as culturing with serum was found to induce iNOS and LPS was able to induce iNOS in the absence of 
serum
Detection of low iNOS mRNA levels in fetal membranes  (FM) by nested RT-PCR, in serum-free cultures Figure 2
Detection of low iNOS mRNA levels in fetal mem-
branes (FM) by nested RT-PCR, in serum-free cul-
tures. Lane 1 fetal membranes immediately after collection, 
lane 2 control (cultured membranes without PAF), lane 3 10 
nM PAF, lane 4 positive control (CHOiNOS cells), lane 5 
PCR blank (no template), lane 6 empty, lanes M ΦX174 
DNA/Hae III marker. The expected size of the product was 
262 base pairs. The faint band below the main band at 262 
base pairs was present in all gels and appeared to be an arte-
fact of nested amplification. This is one example of four iden-
tical results with four different samples of fetal membranes.
Induction of iNOS mRNA expression in human fetal mem- branes (FM) by culturing in the presence of serum for 24  hours Figure 3
Induction of iNOS mRNA expression in human fetal 
membranes (FM) by culturing in the presence of 
serum for 24 hours. Lane 1 fetal membranes immediately 
after collection, lane 2 membranes cultured with serum, lane 
3 membranes cultured with serum and 1 µM PAF, lane 4 pos-
itive control for iNOS, lane 5 PCR blank, M DNA markers. 
The expected size of the product was 310 base pairs. One 
example is shown of three identical results with three differ-
ent samples of fetal membranes. All of the fetal membrane 
samples were initially negative for iNOS mRNA, as detected 
by the standard RT-PCR method.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/29
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ing 150 µl of blocking buffer (3% bovine serum albumin
in phosphate buffered saline) the slides were incubated at
25°C for 5 minutes. The buffer was removed and 100 µl
of primary antibody solution was added, followed by an
overnight incubation in a humidified chamber at 2–8°C.
The slides were washed twice in phosphate buffered
saline, then 150 µl of a secondary antibody (horseradish
peroxidase conjugate – anti-mouse, diluted 1:1000 in
blocking buffer, Dako, Cambridge, UK) solution were
added. The slides were incubated at 25°C for 1 hour and
washed twice. 150 µl of 3,3-diaminobenzidine (DAB)
substrate (1 DAB tablet in 15 ml PBS + 12 ml of 30%
hydrogen peroxide) were added to the slide, and the reac-
tion was allowed to proceed for 8 minutes. The substrate
was rinsed off with distilled water and one drop of Harris
Haemotoxylin was added and incubated for 1 minute.
The stain was rinsed off with distilled water and one drop
of Aquamount mounting medium was placed on the sec-
tion before fixing the cover slide. For the negative controls
the same procedure was followed, but the primary anti-
body was omitted. All reagents were obtained from Sigma
(Poole, UK), unless otherwise stated.
Statistical analysis
Quantitative results are expressed as means ± standard
deviations or standard errors, as indicated. The data were
tested for normal distribution and statistical analysis was
by unpaired T-test or one-way ANOVA using the Bonfer-
roni post hoc test and statistical significance was taken as
P < 0.05.
Results
Tissue culture
The viability of the cells comprising the membrane
explants in culture was greater than 99% during the time
period of the experiments, as assessed by the diaphorase
staining technique and microscopy (results not shown). A
time profile study showed a peak and decline in NO pro-
duction within 24 hours in culture (data not shown). The
fresh membranes were categorised into two groups, those
which were initially active (expressing iNOS) (n = 3) and
those which were initially inactive (not expressing iNOS)
(n = 19), as detected by the standard RT-PCR method (Fig-
ure 1). However, very low levels of iNOS mRNA were
found in all membrane samples by nested RT-PCR (Figure
2). The faint second band of a smaller size than 262 base
pairs was present in all of the nested RT-PCR gels and
appeared to be an artefact of nested amplification. All
membrane samples produced NO in culture, as detected
by the measurement of NO2
- in the culture medium. Cul-
turing the membrane explants with serum consistently (n
= 3) induced the expression of iNOS mRNA (Figure 3),
compared to the fresh membrane samples.
Effects of LPS
In the membrane samples which were initially inactive,
LPS and LPS with sodium butyrate induced the expression
of mRNA for iNOS, compared to control, when cultured
in the absence of serum (n = 4) (Figure 4, Table 1). LPS
and sodium butyrate did not significantly increase the
production of NO2
- by the membrane explants cultured
without serum (n = 4) (Table 1).
Effects of PAF
PAF (1 µM) significantly increased (P < 0.01) the produc-
tion of NO by membrane explants cultured with serum
(Figure 5, Table 1). In the membrane samples which were
initially inactive, PAF (10 nM – 1 µM) did not induce the
expression of mRNA for iNOS, compared to control,
when cultured in the absence of serum (Figure 6, Table 1)
and PAF did not significantly stimulate NO production
under these conditions (Table 1).
Immunohistochemistry
Immunohistochemical staining of samples of fetal mem-
branes showed the presence of iNOS protein in four post-
labour samples (Figure 7), but not in four samples
obtained pre-labour (not shown). The chorion (CR)
showed generalised brown staining for iNOS, also there
was intense staining in the amnion epithelium (AE). In
the amnion (AM), the iNOS expression was more local-
ised. The four samples showed a similar staining pattern.
Discussion
This method for maintaining human fetal membrane
discs in culture has been previously validated [5,19,36])
Induction of iNOS mRNA expression in human fetal mem- branes (FM), cultured without serum Figure 4
Induction of iNOS mRNA expression in human fetal 
membranes (FM), cultured without serum, following 
treatment with LPS (1 µg/ml) alone or in combina-
tion with sodium butyrate (SB) (2 mM). Lane 1 FM 
control; lane 2 FM + LPS; lane 3 FM LPS + SB; lane 4 
CHOiNOS positive control; lane 5 iNOS short standard; 
lane 6 PCR blank (no template); lane M ΦX174 DNA/Hae III 
Marker (Promega). Lanes 2–4 show characteristic iNOS 
bands at 310 base pairs (bp). One example is shown of four 
similar results with four different samples of fetal membranesReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/29
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and the categorisation of fetal membrane samples into
initially active and inactive has been reported previously
[37]. This study found that culturing in the presence of
serum induced iNOS expression, which confirmed
previous findings that culturing with serum can non-spe-
cifically induce the expression of enzymes, such as cyclo-
oxygenase-2 [34]. Numerous growth factors and cytokines
present in serum may have been responsible for this
action, however Cytomix is normally required to induce
iNOS expression [38]. It is possible that the fetal mem-
branes are somehow primed for the expression of iNOS,
compared to other tissues. As culturing with serum was
able to induce iNOS expression, the findings from the
experiments conducted in the absence of serum were per-
haps more important (Table 1). In the present study, LPS
was found to induce iNOS expression in the membrane
explants cultured without serum which were initially inac-
tive. In light of this novel observation, it is possible that
exposure to bacterial products in utero could induce NO
production by the fetal membranes. NO produced by the
Mean concentrations of NO2- in medium of human fetal membrane discs cultured for 24 h with serum Figure 5
Mean concentrations of NO2- in medium of human fetal membrane discs cultured for 24 h with serum under 
control conditions and in the presence of PAF (1 µM). Mean + SEM (n = 3). All of the fetal membrane samples were ini-
tially negative for iNOS mRNA, as detected by the standard RT-PCR method.
0
1
2
3
4
5
6
7
1
Treatment
Control (n = 3)
PAF (1 µM) (n = 3)
P < 0.01Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/29
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membranes adjacent to the cervix could diffuse into the
surrounding tissue and initiate a local inflammatory
reaction, which could lead to premature rupture of the
membranes. The half-life of NO (5–15 seconds under
physiological conditions) is long enough for it to diffuse
through several cell layers and cause subsequent effects.
NO is known to be a potent inflammatory mediator [39]
and to be involved in cervical ripening [24,33]. Intrauter-
ine infection is thought to be a possible initiator of pre-
term labour [2-4]. It should be stressed that the pro-
inflammatory role of NO is being considered here rather
than its well established effect of relaxing the myo-
metrium. There was induction of iNOS expression in fetal
membranes exposed to LPS with sodium butyrate (Figure
4), a known promoter of gene expression [28] and a
metabolite of anaerobic bacteria. In a pregnant murine
model, administration of an inhibitor of NOS, aminogua-
nidine, prevented abortion induced by simultaneous
administration of LPS, suggesting a role for NO produc-
tion in the mechanism of LPS-induced abortion [40].
During validation of the RT-PCR method GAPDH was
used as a housekeeping gene for the gels and a high level
of consistency was found in amounts of total RNA and in
loading the gels with similar amounts of product. Subse-
quently GAPDH was not included on the gels.
The cells expressing iNOS in fetal membranes are likely to
be macrophages or fibroblasts [30], although in the
present study iNOS appeared to be widely expressed. The
membrane explants released NO (detected as NO2
-) into
the culture medium, but the basal production was not fur-
ther stimulated by LPS or sodium butyrate. It is possible
that the NO was produced by a different isoform of NOS,
eNOS or nNOS, which were not detectable using the
methods employed, although the presence of eNOS in
human fetal membranes has been demonstrated
previously by Dennes et al. [29]. It is also possible that
post-transcriptional modulation of iNOS expression dur-
ing the period of culture (24 h) could explain why signif-
icant differences between the production of NO under the
different conditions were not found. Availability of the
substrate L-arginine could have been a limiting factor,
however normally cells have an adequate supply of L-
arginine from metabolism, and the culture medium con-
tained L-arginine. Previous validation experiments involv-
ing supplementing the medium with L-arginine did not
produce increases in NO production, presumably due to
an already adequate availability of L-arginine (unpub-
lished observations). The membrane discs were all of the
No induction of iNOS mRNA expression in human fetal  membranes (FM), cultured without serum Figure 6
No induction of iNOS mRNA expression in human 
fetal membranes (FM), cultured without serum, fol-
lowing treatment with PAF (10 nM). Lane 1 fetal mem-
branes immediately after collection, lane 2 control, lane 3 = 
10 nM PAF, lane 4 positive control, lanes M ΦX174 DNA/
Hae III marker. This is one example of four identical results 
with four different samples of fetal membranes. The fetal 
membrane samples were initially negative for iNOS mRNA, 
as detected by the standard RT-PCR method.
Detection of iNOS protein by immunohistochemical staining  (B) in human fetal membrane sections obtained after vaginal  delivery and (A) negative control (minus the primary  antibody) Figure 7
Detection of iNOS protein by immunohistochemical 
staining (B) in human fetal membrane sections 
obtained after vaginal delivery and (A) negative con-
trol (minus the primary antibody). CR: chorion, AE: 
amnion epithelium, AM: amnion. Bar = 50 µm.
(A)Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/29
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same diameter and approximate thickness, however
responses were variable, so it is possible that any
significant effect of LPS or sodium butyrate on NO pro-
duction may have been obscured by random variation.
In the present study, PAF significantly stimulated NO pro-
duction by the membrane explants cultured with serum.
However, PAF did not induce iNOS expression or stimu-
late NO production in the membrane explants which
were initially inactive and which were cultured without
serum. As PAF stimulated NO production when iNOS was
expressed, but not in the absence of iNOS expression, this
suggests that the mechanism of action of PAF might
involve the direct stimulation of iNOS activity. The exact
mechanism of action of PAF in this case is not clear, how-
ever it is known to have a variety of actions, such as the
activation of GTPase, phospholipase C, D and A2, protein
kinase C and tyrosine kinase [41]. Although many of these
actions lead to the mobilisation of intracellular calcium
ions, the activation of iNOS is calcium independent. It is
possible that PAF could stimulate iNOS activity via an
indirect mechanism. PAF has been shown to induce
expression of primary response genes [41] and it is known
to upregulate gene expression via NF-κB and a G protein-
coupled pathway [42]. PAF has also been shown to acti-
vate NF-κB and enhance its DNA binding activity [43],
however PAF failed to induce iNOS expression in cultured
fetal membranes in this study. The target cells for PAF in
the intact membranes were not identified in this study,
however in a similar study Alvi et al. [44] suggested that
either amnion or decidual cells were the likely targets.
It has been stated that the biochemical role of PAF in
reproduction may not be attributable solely to PAF, but to
other autacoids [11], which could include NO. PAF has
been previously shown to stimulate NOS activity and
prostaglandin synthesis in early pregnant rat uterus [45]
and NO may be the intermediate between PAF and pros-
taglandin synthesis. The PAF antagonist WEB-2170 has
been found to inhibit LPS-induced cervical ripening in
rats [46], suggesting a role for PAF in this mechanism. Elo-
vitz et al. [47] showed that PAF is an important mediator
of inflammation-induced preterm birth in a mouse
model. Again, the pro-inflammatory role of NO is being
considered here, rather than its relaxant role.
An important finding was the lack of expression of iNOS
in pre-labour fetal membranes compared to the general-
ised expression in post-labour samples, detected by
immunohistochemical staining and RT-PCR. This sug-
gests that iNOS is expressed during labour in fetal mem-
branes. This confirms the previously published lack of
expression of iNOS pre-labour reported by Marinoni et al.
[31], but is in contrast to Kakui et al. [32], who reported
similar expression of iNOS in placental tissue from
women in labour and not in labour. The widespread
detection of iNOS in the tissue sections was surprising.
Two specific antibodies to human iNOS (R&D Systems,
Abingdon, UK) were tested and one proved to be of lim-
ited use for immunohistochemical staining (data not
shown), so when the experimental work was conducted
the best antibody available at the time was used. In future
studies blocking experiments and an inhibition assay will
be performed. The induction of iNOS could be caused by
inflammatory mediators, other than PAF, and cytokines
released during labour. The induction of expression of
iNOS could be a key event in the initiation of labour,
however, this observed induction of iNOS could also be as
a result of labour, rather than a cause of it.
Conclusions
This study has provided novel evidence that LPS is able to
induce iNOS expression in intact human fetal membranes
in vitro. If this mechanism occurs in vivo, then it could
provide one possible pathway by which premature labour
could occur in response to intrauterine bacterial infection.
In comparison, PAF was able to stimulate NO production
from intact human fetal membranes in vitro, but not via
the induction of iNOS expression. PAF may have a role as
a mediator in the initiation of term and preterm human
parturition, via the increased local production of nitric
oxide as an inflammatory mediator.
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